Pharmtechnology LLC

Pharmtechnology LLC (Russian: ООО «Фармтехнология») is a Belarusian pharmaceutical company headquartered at 22 Korzhenevskogo Street in Minsk. It operates as a limited liability company (ООО) and describes its mission as improving the quality of life and health of the population by supplying effective, high-quality and safe medicines. The company is registered in Minsk, Belarus, and its corporate website is ft.by. The company develops, manufactures and markets finished pharmaceutical products, with a portfolio that its own website states exceeds 150 medicine names. Its catalogue spans a wide range of therapeutic directions, including gastroenterology, the musculoskeletal system, anti-infective therapy, sensory organs, cold and flu remedies, the nervous system, antiparasitic products, the respiratory system, dermatology and the cardiovascular system. Products are offered in a variety of dosage forms such as tablets, oral and inhalation solutions, and powders for suspension, and are marketed under both international non-proprietary names with the "FT" suffix (for example Azithromycin FT, Amlodipine FT, Amoxicillin FT, Perindopril FT, Etoricoxib FT) and branded trademarks such as Ambrovix, Antenza, Co-Antenza, Xylin with Dexpanthenol, Vialav and C-Derm Trio. Pharmtechnology positions itself around quality, efficacy and safety, and states that it applies a pharmaceutical quality system and the latest technologies in its development work. The company also maintains a pharmacovigilance function, publishing a dedicated round-the-clock contact for adverse-event reporting, and it runs corporate programs covering anti-corruption and personal-data processing. It engages with partners and the press through dedicated sections of its website and invites visitors to tours of its production facility. The company's product range covers both prescription and over-the-counter medicines, reflecting a strategy of serving broad primary-care and specialty demand in the Belarusian market. Its portfolio includes antibiotics and macrolides, mucolytics, calcium-channel blockers, antihypertensives and fixed-dose cardiovascular combinations, among others. Ownership, founding date and financial details are not disclosed in the available public sources.

Pharmtechnology LLC (ООО «Фармтехнология») is a Belarusian pharmaceutical company based in Minsk. Public sources identify it as a company in Minsk, Belarus, operating as a limited liability company. The available evidence does not disclose its founding date, founders or ownership structure, so its early corporate history cannot be reconstructed from the supplied material. What is documented is the company's present-day profile. Its corporate website presents a mission of improving the quality of life and health of the population by providing effective, high-quality and safe medicines, and states that its portfolio comprises more than 150 medicine names. The company describes itself as using the latest technologies in its development work and as operating a pharmaceutical quality system, positioning quality, efficacy and safety as central commitments. Over time the company has built a catalogue spanning a wide set of therapeutic directions: gastroenterology, the musculoskeletal system, anti-infective products, sensory organs, cold remedies, the nervous system, antiparasitic products, the respiratory system, dermatology and the cardiovascular system. Its products are marketed both under international non-proprietary names with the "FT" suffix — such as Azithromycin FT, Amlodipine FT, Amoxicillin FT, Perindopril FT and Etoricoxib FT — and under proprietary trademarks including Ambrovix, Antenza, Co-Antenza, Xylin with Dexpanthenol, Vialav and C-Derm Trio. Dosage forms include tablets, oral and inhalation solutions, and powders for suspension, with products classified as either prescription or over-the-counter. The company maintains a pharmacovigilance function with a dedicated round-the-clock contact for adverse-event reporting, and it publishes corporate policies on anti-corruption and personal-data processing. It also operates partner and press-center sections on its website and invites visitors to tours of its production facility, indicating an active engagement with healthcare professionals, partners and the public. Because the supplied evidence does not include dated events, a detailed chronological history with specific milestones cannot be provided without speculation.

Quality, efficacy and safety-focused manufacturer of a broad generic medicine portfolio for the Belarusian market.

• Azithromycin FT

  Azithromycin 500 mg tablets; macrolide antibacterial for systemic use (ATC J01FA10); prescription.

• Ambrovix

  Ambroxol oral solution and inhalation solution (7.5 mg/ml; 15 mg/5 ml, 30 mg/5 ml); mucolytic for cough and cold (ATC R05CB06); over-the-counter.

• Amlodipine FT

  Amlodipine 5 mg and 10 mg tablets; dihydropyridine calcium-channel blocker (ATC C08CA01); over-the-counter listing.

• Amoxicillin FT

  Amoxicillin powder for suspension 125 mg/5 ml and 250 mg/5 ml; broad-spectrum penicillin (ATC J01CA04).

• Ramipril N

  Ramipril + hydrochlorothiazide combination for cardiovascular therapy.

• Xylin with Dexpanthenol

  Xylometazoline + dexpanthenol nasal product.

• Etoricoxib FT

  Etoricoxib for musculoskeletal indications.

• Antenza

  Amlodipine + perindopril fixed-dose cardiovascular combination.

• Perindopril FT

  Perindopril cardiovascular product.

• Co-Antenza

  Amlodipine + indapamide + perindopril triple fixed-dose combination.

• Vialav

  Sildenafil product.

• C-Derm Trio

  Betamethasone + clotrimazole + gentamicin dermatological combination.

1. 1Главная - ООО «Фармтехнология»ft.by
2. 2Продукция - ООО «Фармтехнология»ft.by
3. 3Pharmtechnology LLC (Belarus) - Wikidatawikidata.org